The estimated Net Worth of James Charles Miller is at least $58.4 Tysiąc dollars as of 17 November 2021. James Miller owns over 1,000 units of Recro Pharma Inc stock worth over $58,359 and over the last 4 years James sold REPH stock worth over $0.
James has made over 1 trades of the Recro Pharma Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently James bought 1,000 units of REPH stock worth $1,690 on 17 November 2021.
The largest trade James's ever made was buying 1,000 units of Recro Pharma Inc stock on 17 November 2021 worth over $1,690. On average, James trades about 333 units every 0 days since 2021. As of 17 November 2021 James still owns at least 27,923 units of Recro Pharma Inc stock.
You can see the complete history of James Miller stock trades at the bottom of the page.
James's mailing address filed with the SEC is C/O RECRO PHARMA, INC., 1 E UWCHLAN AVE, SUITE 112, EXTON, PA, 19341.
Over the last 11 years, insiders at Recro Pharma Inc have traded over $25,533,136 worth of Recro Pharma Inc stock and bought 3,055,820 units worth $22,429,197 . The most active insiders traders include Healthcare Master Fund Ltd ..., Investment Company, Inc. Awm oraz James E Deerfield Mgmt L.P..... On average, Recro Pharma Inc executives and independent directors trade stock every 31 days with the average trade being worth of $151,953. The most recent stock trade was executed by J David Jr Enloe on 15 March 2022, trading 512 units of REPH stock currently worth $1,004.
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.
Recro Pharma Inc executives and other stock owners filed with the SEC include: